Kenneth C. Olson
12Patents
9h-index
18Co-inventors
69Inventor score
Filing activity: Jun 1, 1984 → Jul 10, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4511503A | Purification and activity assurance of precipitated heterologous proteins | Emerging Cross-Sectional Technologies | 228 | Expired |
| US4512922A | Purification and activity assurance of precipitated heterologous proteins | Emerging Cross-Sectional Technologies | 207 | Expired |
| US5849535A | Human growth hormone variants | Emerging Cross-Sectional Technologies | 153 | Expired |
| US4518526A | Purification and activity assurance of precipitated heterologous proteins | Emerging Cross-Sectional Technologies | 107 | Expired |
| US6057292A | Method for inhibiting growth hormone action | Emerging Cross-Sectional Technologies | 101 | Expired |
| US8338375B2 | Packaged product | Human Necessities | 67 | Active |
| US6004931A | Method for inhibiting growth hormone action | Emerging Cross-Sectional Technologies | 46 | Expired |
| US6136563A | Human growth hormone variants comprising amino acid substitutions | Emerging Cross-Sectional Technologies | 29 | Expired |
| US8697044B2 | Crossed-linked hyaluronic acid and collagen and uses thereof | Human Necessities | 14 | Active |
| US4680262A | Periplasmic protein recovery | Emerging Cross-Sectional Technologies | 9 | Expired |
| US8703118B2 | Crossed-linked hyaluronic acid and collagen and uses thereof | Human Necessities | 3 | Active |
| US11396653B2 | System for the biocontrol of disease-transmitting mosquitoes and their eggs using horizontally transferable symbiotic bacteria to deliver pathogen specific interfering RNA polynucleotides | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.